Viewing Study NCT01045161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:01 PM
Ignite Modification Date: 2026-01-31 @ 8:00 PM
Study NCT ID: NCT01045161
Status: COMPLETED
Last Update Posted: 2017-01-23
First Post: 2010-01-07
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Obstructive Pulmonary Disease View
None COPD View
None Chronic Bronchitis View
None Emphysema View
None Airflow Obstruction, Chronic View
None Chronic Airflow Obstruction View
None Chronic Obstructive Airway Disease View
None Chronic Obstructive Lung Disease View